|
Fusion gene ID: 43301 |
FusionGeneSummary for ZNF420_SULT2B1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ZNF420_SULT2B1 | Fusion gene ID: 43301 | Hgene | Tgene | Gene symbol | ZNF420 | SULT2B1 | Gene ID | 147923 | 6820 |
Gene name | zinc finger protein 420 | sulfotransferase family 2B member 1 | |
Synonyms | APAK | ARCI14|HSST2 | |
Cytomap | 19q13.12 | 19q13.33 | |
Type of gene | protein-coding | protein-coding | |
Description | zinc finger protein 420ATM and p53-associated KZNF protein | sulfotransferase family cytosolic 2B member 1ST2B1alcohol sulfotransferasehydroxysteroid sulfotransferase 2hydroxysteroid sulfotransferase SULT2B1asulfotransferase 2B1sulfotransferase family, cytosolic, 2B, member 1 | |
Modification date | 20180522 | 20180519 | |
UniProtAcc | Q8TAQ5 | O00204 | |
Ensembl transtripts involved in fusion gene | ENST00000304239, ENST00000337995, ENST00000586540, | ENST00000201586, ENST00000323090, ENST00000594274, | |
Fusion gene scores | * DoF score | 6 X 4 X 6=144 | 2 X 2 X 2=8 |
# samples | 7 | 2 | |
** MAII score | log2(7/144*10)=-1.04064198449735 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: ZNF420 [Title/Abstract] AND SULT2B1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SULT2B1 | GO:0008202 | steroid metabolic process | 9799594|12145317 |
Tgene | SULT2B1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 12923182 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | KIRP | TCGA-4A-A93Y-01A | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000304239 | ENST00000201586 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-3CDS | ENST00000304239 | ENST00000323090 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-intron | ENST00000304239 | ENST00000594274 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-3CDS | ENST00000337995 | ENST00000201586 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-3CDS | ENST00000337995 | ENST00000323090 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-intron | ENST00000337995 | ENST00000594274 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-3CDS | ENST00000586540 | ENST00000201586 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-3CDS | ENST00000586540 | ENST00000323090 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
intron-intron | ENST00000586540 | ENST00000594274 | ZNF420 | chr19 | 37498984 | + | SULT2B1 | chr19 | 49079198 | + |
Top |
FusionProtFeatures for ZNF420_SULT2B1 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ZNF420 | SULT2B1 |
May be involved in transcriptional regulation. | Sulfotransferase that utilizes 3'-phospho-5'-adenylylsulfate (PAPS) as sulfonate donor to catalyze the sulfateconjugation of many hormones, neurotransmitters, drugs andxenobiotic compounds. Sulfonation increases the water solubilityof most compounds, and therefore their renal excretion, but it canalso result in bioactivation to form active metabolites. Sulfateshydroxysteroids like DHEA. Isoform 1 preferentially sulfonatescholesterol, and isoform 2 avidly sulfonates pregnenolone but notcholesterol. Plays a role in epidermal cholesterol metabolism andin the regulation of epidermal proliferation and differentiation(PubMed:28575648). {ECO:0000269|PubMed:12145317,ECO:0000269|PubMed:28575648, ECO:0000269|PubMed:9799594}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ZNF420_SULT2B1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ZNF420_SULT2B1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ZNF420 | TP53, CDC42, CDKN2A, CYP4V2, SLC1A7, HAX1, CYP51A1, TNFRSF1B, CDK2AP1, TRIM28, MDM2, UBE2I, SENP1, SAV1, RBM4, STK3, H2AFX, NR3C1 | SULT2B1 | SULT1E1, ALS2CR12, ACYP2, PRICKLE3, SULT1A1, SULT2B1, SULT1B1, DDX19B, GMCL1, TBC1D22B, FCF1, CDK15 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ZNF420_SULT2B1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | SULT2B1 | O00204 | DB01708 | Prasterone | Sulfotransferase family cytosolic 2B member 1 | small molecule | approved|investigational|nutraceutical |
Top |
RelatedDiseases for ZNF420_SULT2B1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | SULT2B1 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
Tgene | SULT2B1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |